ID WSU-FSCCL AC CVCL_1903 SY WSUFSCCL DR EFO; EFO_0006776 DR ArrayExpress; E-MTAB-2706 DR BioSample; SAMN03472504 DR DepMap; ACH-001708 DR DSMZ; ACC-612 DR DSMZCellDive; ACC-612 DR EGA; EGAS00001000610 DR EGA; EGAS00001002554 DR GEO; GSM1308987 DR GEO; GSM1308988 DR GEO; GSM1308989 DR GEO; GSM1308990 DR PharmacoDB; WSUFSCCL_1676_2019 DR Wikidata; Q54994468 RX DOI=10.1016/B978-0-12-221970-2.50457-5; RX PubMed=8221615; RX PubMed=25485619; RX PubMed=25877200; RX PubMed=26589293; RX PubMed=28196595; WW Info; MCLP; -; https://tcpaportal.org/mclp/ WW Provider; BioIVT/Asterand; -; https://bioivt.com/wsu-heme-onc-cell-lines CC Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE). CC Part of: MD Anderson Cell Lines Project. CC Doubling time: ~26 hours (PubMed=8221615); ~20-30 hours (DSMZ=ACC-612). CC HLA typing: A*02:01,02:01; B*27:05,44:02; C*01:02,05:01; DQA1*02:01,03:02; DQB1*03:02,03:02; DRB1*04:04,07:01 (PubMed=26589293). CC Omics: Genomics; Whole exome sequencing. CC Omics: Proteomics; Expression; Reverse-phase protein array. CC Omics: Transcriptomics; Microarray. CC Omics: Transcriptomics; RNAseq. CC Omics: Variations; SNP array analysis. CC Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. ST Source(s): DSMZ=ACC-612; PubMed=25877200 ST Amelogenin: X,Y ST CSF1PO: 12 ST D13S317: 11,13 ST D16S539: 11,13 ST D18S51: 13,14 ST D19S433: 14 ST D21S11: 30 ST D2S1338: 23,24 ST D3S1358: 15,16 ST D5S818: 12 ST D7S820: 10,13 ST D8S1179: 12,14 ST FGA: 22,24 ST Penta D: 9,13 ST Penta E: 7,12 ST TH01: 9.3 ST TPOX: 11 ST vWA: 18,20 DI NCIt; C3465; Grade 1 follicular lymphoma DI ORDO; Orphanet_545; Follicular lymphoma OX NCBI_TaxID=9606; ! Homo sapiens (Human) SX Male AG 37Y CA Cancer cell line DT Created: 04-04-12; Last updated: 10-04-25; Version: 30 // RX PubMed=25485619; DOI=10.1038/nbt.3080; RA Klijn, Christiaan RA Durinck, Steffen RA Stawiski, Eric W. RA Haverty, Peter M. RA Jiang, Zhao-Shi RA Liu, Han-Bin RA Degenhardt, Jeremiah RA Mayba, Oleg RA Gnad, Florian RA Liu, Jin-Feng RA Pau, Gregoire RA Reeder, Jens RA Cao, Yi RA Mukhyala, Kiran RA Selvaraj, Suresh K. RA Yu, Ma-Mie RA Zynda, Gregory J. RA Brauer, Matthew J. RA Wu, Thomas D. RA Gentleman, Robert Clifford RA Manning, Gerard RA Yauch, Robert L. RA Bourgon, Richard RA Stokoe, David RA Modrusan, Zora RA Neve, Richard M. RA de Sauvage, Frederic J. RA Settleman, Jeffrey RA Seshagiri, Somasekar RA Zhang, Ze-Min RT "A comprehensive transcriptional portrait of human cancer cell RT lines."; RL Nat. Biotechnol. 33:306-312(2015). // RX PubMed=26589293; DOI=10.1186/s13073-015-0240-5; PMCID=PMC4653878; RA Scholtalbers, Jelle RA Boegel, Sebastian RA Bukur, Thomas RA Byl, Marius RA Goerges, Sebastian RA Sorn, Patrick RA Loewer, Martin RA Sahin, Ugur RA Castle, John C. RT "TCLP: an online cancer cell line catalogue integrating HLA type, RT predicted neo-epitopes, virus and gene expression."; RL Genome Med. 7:118.1-118.7(2015). // RX DOI=10.1016/B978-0-12-221970-2.50457-5; RA Drexler, Hans Gunther RT "The leukemia-lymphoma cell line factsbook."; RL (In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001). // RX PubMed=25877200; DOI=10.1038/nature14397; RA Yu, Ma-Mie RA Selvaraj, Suresh K. RA Liang-Chu, May M.Y. RA Aghajani, Sahar RA Busse, Matthew RA Yuan, Jean RA Lee, Genee RA Peale, Franklin V. RA Klijn, Christiaan RA Bourgon, Richard RA Kaminker, Joshua S. RA Neve, Richard M. RT "A resource for cell line authentication, annotation and quality RT control."; RL Nature 520:307-311(2015). // RX PubMed=28196595; DOI=10.1016/j.ccell.2017.01.005; PMCID=PMC5501076; RA Li, Jun RA Zhao, Wei RA Akbani, Rehan RA Liu, Wen-Bin RA Ju, Zhen-Lin RA Ling, Shi-Yun RA Vellano, Christopher P. RA Roebuck, Paul RA Yu, Qing-Hua RA Eterovic, A. Karina RA Byers, Lauren Averett RA Davies, Michael A. RA Deng, Wan-Leng RA Gopal, Y.N. Vashisht RA Chen, Guo RA von Euw, Erika Maria RA Slamon, Dennis Joseph RA Conklin, Dylan RA Heymach, John Victor RA Gazdar, Adi F. RA Minna, John D. RA Myers, Jeffrey N. RA Lu, Yi-Ling RA Mills, Gordon B. RA Liang, Han RT "Characterization of human cancer cell lines by reverse-phase protein RT arrays."; RL Cancer Cell 31:225-239(2017). // RX PubMed=8221615; DOI=10.1016/0165-4608(93)90132-6; RA Mohammad, Ramzi M. RA Mohamed, Anwar N. RA Smith, Mitchell R. RA Jawadi, Nasreen S. RA Al-Katib, Ayad M. RT "A unique EBV-negative low-grade lymphoma line (WSU-FSCCL) exhibiting RT both t(14;18) and t(8;11)."; RL Cancer Genet. Cytogenet. 70:62-67(1993). //